#heart drug
Related Stories (2)
Novartis, Ionis' experimental heart drug misses key goal in closely watched trial - Reuters
Novartis, Ionis' experimental heart drug misses key goal in closely watched trial Reuters
September 4, 2026Heart drug developer Kardigan targets $1.4 billion valuation in US IPO - Reuters
Heart drug developer Kardigan targets $1.4 billion valuation in US IPO Reuters
June 11, 2026Related Pages (2)
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
news.google.com•September 5, 2026
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
news.google.com•June 14, 2026